Singapore-based medical robotics company EndoMaster has closed a S$20.5 million ($14.6 million) Series B funding round. No investors were disclosed.
Among the largest investments in local medical technology (medtech) companies in the city-state, the Thursday announcement sees the firm, which has developed proprietary robotic technology and algorithms, preparing to launch its product in Europe in late 2018. The funding was initially reported by The Business Times.
